314 related articles for article (PubMed ID: 28514931)
1. Lung cancer in never-smokers - what are the differences?
Dias M; Linhas R; Campainha S; Conde S; Barroso A
Acta Oncol; 2017 Jul; 56(7):931-935. PubMed ID: 28514931
[TBL] [Abstract][Full Text] [Related]
2. Evolving epidemiology of lung cancer in India: Reducing non-small cell lung cancer-not otherwise specified and quantifying tobacco smoke exposure are the key.
Kaur H; Sehgal IS; Bal A; Gupta N; Behera D; Das A; Singh N
Indian J Cancer; 2017; 54(1):285-290. PubMed ID: 29199707
[TBL] [Abstract][Full Text] [Related]
3. Non-small cell lung cancer in never smokers: a clinical entity to be identified.
Santoro IL; Ramos RP; Franceschini J; Jamnik S; Fernandes AL
Clinics (Sao Paulo); 2011; 66(11):1873-7. PubMed ID: 22086516
[TBL] [Abstract][Full Text] [Related]
4. Proportion and clinical features of never-smokers with non-small cell lung cancer.
Cho J; Choi SM; Lee J; Lee CH; Lee SM; Kim DW; Yim JJ; Kim YT; Yoo CG; Kim YW; Han SK; Park YS
Chin J Cancer; 2017 Feb; 36(1):20. PubMed ID: 28179026
[TBL] [Abstract][Full Text] [Related]
5. The prognostic impact of the amount of tobacco smoking in non-small cell lung cancer--differences between adenocarcinoma and squamous cell carcinoma.
Okamoto T; Suzuki Y; Fujishita T; Kitahara H; Shimamatsu S; Kohno M; Morodomi Y; Kawano D; Maehara Y
Lung Cancer; 2014 Aug; 85(2):125-30. PubMed ID: 24976334
[TBL] [Abstract][Full Text] [Related]
6. Non-small cell lung cancer in never smokers as a representative 'non-smoking-associated lung cancer': epidemiology and clinical features.
Yano T; Haro A; Shikada Y; Maruyama R; Maehara Y
Int J Clin Oncol; 2011 Aug; 16(4):287-93. PubMed ID: 21562939
[TBL] [Abstract][Full Text] [Related]
7. The clinicopathological and survival differences between never and ever smokers with non-small cell lung cancer.
Muallaoglu S; Karadeniz C; Mertsoylu H; Ayberk Besen A; Sezer A; Murat Sedef A; Kose F; Ozyilkan O
J BUON; 2014; 19(2):453-8. PubMed ID: 24965406
[TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics and survival in never smokers with lung cancer.
Parente Lamelas I; Abal Arca J; Blanco Cid N; Alves Pérez MT; Dacal Quintas R; Gómez Márquez H; García Montenegro RA; Marcos Velázquez P
Arch Bronconeumol; 2014 Feb; 50(2):62-6. PubMed ID: 24280242
[TBL] [Abstract][Full Text] [Related]
9. Multiple primary malignancies in patients with non-small cell lung cancer.
Fujita S; Masago K; Takeshita J; Togashi Y; Hata A; Kaji R; Kokubo M; Katakami N
Intern Med; 2015; 54(3):325-31. PubMed ID: 25748742
[TBL] [Abstract][Full Text] [Related]
10. Differences in epidemiology, histology, and survival between cigarette smokers and never-smokers who develop non-small cell lung cancer.
Bryant A; Cerfolio RJ
Chest; 2007 Jul; 132(1):185-92. PubMed ID: 17573517
[TBL] [Abstract][Full Text] [Related]
11. Effect of histologic type and smoking status on interpretation of serum carcinoembryonic antigen value in non-small cell lung carcinoma.
Okada M; Nishio W; Sakamoto T; Uchino K; Yuki T; Nakagawa A; Tsubota N
Ann Thorac Surg; 2004 Sep; 78(3):1004-9; discussion 1009-10. PubMed ID: 15337038
[TBL] [Abstract][Full Text] [Related]
12. Clinico-pathology of lung cancer in a regional cancer center in Northeastern India.
Mandal SK; Singh TT; Sharma TD; Amrithalingam V
Asian Pac J Cancer Prev; 2013; 14(12):7277-81. PubMed ID: 24460288
[TBL] [Abstract][Full Text] [Related]
13. Presentation and stage-specific outcomes of lifelong never-smokers with non-small cell lung cancer (NSCLC).
Subramanian J; Velcheti V; Gao F; Govindan R
J Thorac Oncol; 2007 Sep; 2(9):827-30. PubMed ID: 17805060
[TBL] [Abstract][Full Text] [Related]
14. Never-smokers with lung cancer: epidemiologic evidence of a distinct disease entity.
Toh CK; Gao F; Lim WT; Leong SS; Fong KW; Yap SP; Hsu AA; Eng P; Koong HN; Thirugnanam A; Tan EH
J Clin Oncol; 2006 May; 24(15):2245-51. PubMed ID: 16710022
[TBL] [Abstract][Full Text] [Related]
15. Role of Low-Dose Computerized Tomography in Lung Cancer Screening among Never-Smokers.
Kang HR; Cho JY; Lee SH; Lee YJ; Park JS; Cho YJ; Yoon HI; Lee KW; Lee JH; Lee CT
J Thorac Oncol; 2019 Mar; 14(3):436-444. PubMed ID: 30445189
[TBL] [Abstract][Full Text] [Related]
16. Performance status and smoking status are independent favorable prognostic factors for survival in non-small cell lung cancer: a comprehensive analysis of 26,957 patients with NSCLC.
Kawaguchi T; Takada M; Kubo A; Matsumura A; Fukai S; Tamura A; Saito R; Maruyama Y; Kawahara M; Ignatius Ou SH
J Thorac Oncol; 2010 May; 5(5):620-30. PubMed ID: 20354456
[TBL] [Abstract][Full Text] [Related]
17. Epidemiological changes in the histological subtypes of 35,018 non-small-cell lung cancer cases in Brazil.
Costa G; Thuler LC; Ferreira CG
Lung Cancer; 2016 Jul; 97():66-72. PubMed ID: 27237030
[TBL] [Abstract][Full Text] [Related]
18. Sensitivity to epidermal growth factor receptor tyrosine kinase inhibitors in males, smokers, and non-adenocarcinoma lung cancer in patients with EGFR mutations.
Zeng Z; Chen HJ; Yan HH; Yang JJ; Zhang XC; Wu YL
Int J Biol Markers; 2013 Sep; 28(3):249-58. PubMed ID: 23873621
[TBL] [Abstract][Full Text] [Related]
19. [Lung cancer at a university hospital: epidemiological and histological characteristics of a recent and a historical series].
Santos-Martínez MJ; Curull V; Blanco ML; Macià F; Mojal S; Vila J; Broquetas JM
Arch Bronconeumol; 2005 Jun; 41(6):307-12. PubMed ID: 15989887
[TBL] [Abstract][Full Text] [Related]
20. Gender, histology, and time of diagnosis are important factors for prognosis: analysis of 1499 never-smokers with advanced non-small cell lung cancer in Japan.
Kawaguchi T; Takada M; Kubo A; Matsumura A; Fukai S; Tamura A; Saito R; Kawahara M; Maruyama Y
J Thorac Oncol; 2010 Jul; 5(7):1011-7. PubMed ID: 20502360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
